Oyster Point Pharma, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Oyster Point Pharma, Inc. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $36.70 million as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2022-05-05
- 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $36.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2022-03-31 | $36.70M 10-Q · filed 2022-05-05 |